Knowledge · Natural Compounds

Ashwagandha

Ashwagandha (winter cherry) is an Ayurvedic plant; human studies show improvements in stress, sleep, hormones, performance and cognition.

Last updated:

We evaluated 179 human studies on Ashwagandha, including 94 randomised controlled trials and 38 meta-analyses or systematic reviews; the controlled studies include 7,658 participants in total. As of 3 October 2026.

This page as PDF · Summary

1. What Is Ashwagandha? Occurrence, Origin and Forms

Ashwagandha (Withania somnifera), also known as winter cherry, is a plant of the nightshade family and has been part of India's Ayurvedic medicine for centuries. Its most important constituents are considered to be the withanolides.

The plant grows in dry regions of India, the Middle East and Africa and is cultivated mainly in India. Mostly the roots are used, less often the leaves and berries.

Products include dried root powder and extracts made with water or water-alcohol mixtures, usually standardised to a certain withanolide content. Many studies use named extracts from the root or from root and leaf.

Forms and Preparations Studied

  • Root powder
  • Standardised root extracts, such as KSM-66 or Shoden
  • Root-and-leaf extracts, such as Sensoril
  • Preparations applied to skin and hair
  • Combination products with ashwagandha – the other ingredients are named in each case

Not covered on this page:

  • Multi-herb Ayurvedic formulas in which the ashwagandha content is not stated → Adaptogens
  • Isolated withanolides such as withaferin A in laboratory and animal experiments

2. What Does Ashwagandha Do? Results by Area

AreaResult in controlled studiesStrength of evidenceStudiesParticipants
Stress and anxietymostly improvedhigh15 meta-analyses · 42 controlled · 16 other2,749
Hormones and fertilitymostly improvedhigh11 meta-analyses · 23 controlled · 10 other1,441
Sleepmostly improvedhigh5 meta-analyses · 26 controlled · 13 other1,752
Memory and concentrationmostly improvedhigh3 meta-analyses · 16 controlled · 5 other503
Physical performance and muscle strengthmostly improvedhigh5 meta-analyses · 14 controlled · 7 other521
Metabolism, blood sugar and weightmostly improvedhigh6 meta-analyses · 8 controlled · 5 other329
Thyroidmostly no differencemoderate5 meta-analyses · 3 controlled · 3 other170
Skin and hairmostly improvedmoderate0 meta-analyses · 4 controlled · 1 other61
Other outcomesmostly improvedhigh13 meta-analyses · 68 controlled · 39 other6,261

How to read the table: counted are human studies whose results concern the area. “High” means at least one meta-analysis and two controlled studies showing improvement, or at least three controlled studies of which three quarters show improvement, with at least 300 participants in total. “Moderate” means at least two controlled studies showing improvement, as a majority, or one meta-analysis alongside controlled studies. “Low” means one controlled study showing improvement. Where an area has no controlled study, the strength of evidence is at most “low” (result “reviews only” or “observational data only”). Everything else is “unclear”. A study counts as showing improvement when at least half of its outcomes in this area improved. Reviews of combination products do not count as meta-analyses; results that only describe side effects or shares of users do not count as an effect. The same study is counted only once.

3. What the Studies Show in Detail

Ashwagandha, Stress and Anxiety: Human Studies

Ashwagandha extracts lowered perceived stress more than placebo in several randomized controlled studies 47535678. Anxiety improved more than with placebo in several randomized controlled studies 4659757884. One meta-analysis confirmed advantages for perceived stress, anxiety and serum cortisol 10; another saw an advantage only for cortisol, not for perceived stress 11. Cortisol fell more than with placebo in several randomized controlled studies 537884, while in others there was no difference 4659129. Skin conductance and heart rate variability improved compared with placebo 59, as did the cortisol response to a stress test 74. Fatigue and recovery also improved in individual randomized controlled studies 85127, while another found no difference 129. Individual randomized controlled studies found no difference in perceived stress 94121124. Mainly standardized root extracts were studied, as well as root powder and extracts from root and leaf. The evidence is strong, but many studies are small and short, and the extract forms are inconsistent, so it remains open which preparation and dose work most reliably.

StudyDesign · participantsPreparation · dose · duration · comparisonResult
1 Ferreira et al. 2025systematic review · 9,005 participantsAshwagandha supplementation; mostly 500–1000 mg per dayanxiety reduction: improved
2 Coope et al. 2026systematic review · 2,317 participantsStandardised Ashwagandha root extract (SARE), root only; 125 to 600 mg/day; Single dose to 180 days; vs. Comparator groups in randomised trialsCortisol: improved
4 Fornalik et al. 2026meta-analysis · 1,706 participantsOral ashwagandha supplementation (Withania somnifera); not reported; subgroups by withanolide content; vs. PlaceboCortisol: improved (SMD =- 1.18, p < 0.04)
7 Akhgarjand et al. 2022meta-analysis · 1,002 participantsAshwagandha extract (supplementation); 300–600 mg/d for stress; up to 12,000 mg/d for anxiety; vs. PlaceboAnxiety level: improved (SMD: -1.55, 95% CI: -2.37, -0.74; p = .005); Stress level: improved (SMD: -1.75; 95% CI: -2.29, -1.22; p = .005)
10 Arumugam et al. 2024meta-analysis · 558 participantsAshwagandha formulations (not further specified); vs. PlaceboPerceived Stress Scale (PSS): improved (MD = -4.72, 95 % CI = [-8.45 to -0.99]); Hamilton Anxiety Scale (HAS): improved (MD = -2.19, 95 % CI = [-3.83 to -0.55]); Serum cortisol levels: improved (MD = -2.58, 95 % CI = [-4.99 to -0.16])
11 Albalawi et al. 2025meta-analysis · 488 participantsAshwagandha (Withania somnifera), oral dose ≥250 mg/day; ≥250 mg/day; ≥2 weeks; vs. Control groups of included RCTsCortisol levels: improved (-1.16 µg/dL, 95% CI: -1.64 to -0.69, P < 0.001); Perceived stress (PSS): no difference (SMD = -0.355, 95% CI: -1.188 to 0.47; P = 0.40)
12 Cheah et al. 2021meta-analysis · 400 participantsAshwagandha extract; Subgroup ≥600 mg/day; Subgroup ≥8 weeks; vs. PlaceboAnxiety level: improved
13 Fatima et al. 2024meta-analysis · 254 participantsWithania somnifera extracts; vs. PlaceboHamilton Anxiety Scale (HAM-A): improved (MD = -5.96; [95% CI -10.34, -1.59]; P = 0.008; I2 = 98%)

Further studies in this area: 18 20 23 25 26 31 34 38 43 44 46 47 49 50 51 52 53 54 56 59 65 67 68 71 72 74 75 76 77 78 80 82 83 84 85 87 88 94 98 101 108 109 114 117 121 122 124 127 129 130 139 140 151 152 154 156 160 161 162 165 166 171 172 174 177

Ashwagandha, Hormones and Fertility: Human Studies

In healthy men 5766 and in men with reduced sperm count 132, sperm values improved more with root extract than with placebo. Sexual function also improved more in men than with placebo in several randomized controlled studies 5766123. Testosterone rose more in men than with placebo in several randomized controlled studies 7886123129; a meta-analysis found the increase in men, not in women 4. In menopausal women, root extract alleviated complaints and lowered FSH and LH more than placebo 5876. A combination preparation of Ashwagandha with Shilajit, ginger, black pepper, Mucuna pruriens and Akarkara improved testosterone and cortisol in a controlled study 69, while a combination with Shatavari root extract showed no change in serum hormones 49. The findings apply to the form studied in each case, mostly standardized root extracts, and cannot be transferred to all preparations; long-term effects and the active ingredients responsible remain open.

StudyDesign · participantsPreparation · dose · duration · comparisonResult
1 Ferreira et al. 2025systematic review · 9,005 participantsAshwagandha supplementation; mostly 500–1000 mg per daysexual function: improved
2 Coope et al. 2026systematic review · 2,317 participantsStandardised Ashwagandha root extract (SARE), root only; 125 to 600 mg/day; Single dose to 180 days; vs. Comparator groups in randomised trialsTestosterone: unclear
4 Fornalik et al. 2026meta-analysis · 1,706 participantsOral ashwagandha supplementation (Withania somnifera); not reported; subgroups by withanolide content; vs. PlaceboTestosterone in men: improved (MD = 57.43 ng/dl); Testosterone in women: no difference (MD = 5.09 ng/dl); Estradiol (E2): no difference
5 Zhu et al. 2026meta-analysis · 1,249 participantsAshwagandha supplementation (Withania somnifera); vs. Control (placebo or no supplementation)Testosterone: improved (SMD = 0.33; 95% CI: 0.13-0.54; P = 0.001)
6 Ahmadian et al. 2022systematic review · 1,218 participantsWithania somnifera roots and other herbal medicines; vs. various herbal medicines comparedtreatment success in male infertility: improved (12 cases were effective in treating male infertility)
18 Łuszczak et al. 2026systematic reviewStandardized extracts of Withania somnifera and Rhodiola rosea; W. somnifera 120-1000 mg/day; R. rosea 290-1500 mg/day; 3-16 weeks; vs. Control groups of included RCTsHormonal changes: improved
21 Tallon et al. 2026systematic reviewAshwagandha (Withania somnifera), unspecified; vs. no control group; narrative evidence assessmentReproductive toxicity and abortifacient activity: unclear (remains inconclusive); Hormonal balance: no difference (no adverse effects); Reproductive health: no difference (no adverse effects)
22 Roy et al. 2026systematic reviewAshwagandha (form not specified)Sexual health and fertility: improved; Reproductive disorders (e.g. PCOS, sperm quality): improved

Further studies in this area: 23 28 30 34 47 49 50 55 57 58 61 66 69 72 75 76 77 78 84 86 88 95 113 121 123 129 132 137 148 152 158 159 162 164 166 176

Ashwagandha and Sleep: Human Studies

In sleep problems, standardized root extracts of winter cherry showed better sleep quality, shorter sleep onset latency, longer sleep duration and higher sleep efficiency in several controlled studies 456582. The time awake after falling asleep also improved 4565. Daytime sleepiness decreased more in older people than under placebo 89; a systematic review considers ashwagandha root promising for insomnia 34. Randomized controlled trials also found better sleep quality for a sustained-release root extract 4753 and for the formulation Zenroot™ 59. For total time in bed, there was no difference 13. Some of the studies examined mixtures with melatonin 43, shatavari root extract 48 or Abelmoschus esculentus 51 or the addition to iron therapy in pregnancy 67. A controlled, non-randomized study was funded by the manufacturer 133. The strength of evidence is high, but the doses, extracts and treatment durations studied differ, and for root powder as well as preparations for application to skin and hair, reliable sleep data are lacking.

StudyDesign · participantsPreparation · dose · duration · comparisonResult
1 Ferreira et al. 2025systematic review · 9,005 participantsAshwagandha supplementation; mostly 500–1000 mg per daysleep quality: improved
12 Cheah et al. 2021meta-analysis · 400 participantsAshwagandha extract; Subgroup ≥600 mg/day; Subgroup ≥8 weeks; vs. PlaceboOverall sleep (quantity and quality): improved (Standardized Mean Difference -0.59; 95% Confidence Interval -0.75 to -0.42; I2 = 62%)
13 Fatima et al. 2024meta-analysis · 254 participantsWithania somnifera extracts; vs. PlaceboSleep Onset Latency (SOL): improved; Total Sleep Time (TST): improved; Pittsburgh Sleep Quality Index (PSQI): improved
18 Łuszczak et al. 2026systematic reviewStandardized extracts of Withania somnifera and Rhodiola rosea; W. somnifera 120-1000 mg/day; R. rosea 290-1500 mg/day; 3-16 weeks; vs. Control groups of included RCTsSleep quality: improved
19 Kulkarni et al. 2026systematic reviewAyurvedic therapies including Ashwagandha; vs. no comparator in most studiesimprovement of insomnia: improved
25 Marchi et al. 2025systematic reviewWithania somnifera (Ashwagandha); median 600 mg/day orally; one study Shirodhara; median 8 weeks follow-up; vs. any comparator (randomised controlled trials)sleep quality (SMD): improved (SMD: -1.35 (95% CI: -1.79; -0.91))
34 Tandon et al. 2020systematic reviewAshwagandha root preparationsEfficacy in insomnia: improved
43 Movva et al. 2026randomised controlled · 200 participantsAshwagandha root extract (ARE), melatonin (MLT), combination, or placebo; ARE 300 mg twice daily; MLT 3 mg/day; combination ARE 600 mg/day + MLT 3 mg/day; eight weeks; vs. placebo; ARE monotherapy vs. MLT monotherapy vs. combinationsleep onset latency (SOL): improved (p < 0.0001); total sleep time (TST): improved (p < 0.0001); wake after sleep onset (WASO): improved (p < 0.0001)

Further studies in this area: 45 47 48 50 51 53 59 65 67 68 80 81 82 83 89 104 108 109 114 116 117 124 125 128 133 147 151 153 154 160 161 162 165 166 172 174

Ashwagandha, Memory and Concentration: Human Studies

In several randomized controlled trials, ashwagandha extracts improved memory more than placebo, in healthy adults, in mild cognitive impairment and in children 538591104. Attention was also better in several controlled studies 8591105135. Working memory improved in several controlled studies 96104105135. Executive function was better than under placebo in several randomized controlled trials 91104109. Reaction time was better in several controlled studies 85104. Mental alertness was better in several controlled studies 6580128. A randomized controlled trial with a root-leaf extract with a liposomal coating found better results for word recall, image recognition and reaction time 85. A randomized controlled trial with a combination preparation of ashwagandha and piperine showed better multitasking and concentration performance 87. A randomized controlled trial with a combination preparation of ashwagandha and Andrographis paniculata found better attention and concentration performance 101. A meta-analysis found advantages for memory, attention, executive function and visuospatial abilities 5; a systematic review evaluates the studies as early indications 35. The studies examined predominantly adults, some with mild cognitive impairment, children and adolescents with ADHD as well as healthy older people. It remains open which ingredients and dosages are decisive for the effects.

StudyDesign · participantsPreparation · dose · duration · comparisonResult
5 Zhu et al. 2026meta-analysis · 1,249 participantsAshwagandha supplementation (Withania somnifera); vs. Control (placebo or no supplementation)Memory: improved (SMD = 0.52; 95% CI: 0.27-0.78; P < 0.001); Attention and processing speed: improved (SMD = 0.29; 95% CI: 0.07-0.51; P = 0.009); Executive function: improved (SMD = -0.42; 95% CI: -0.70 to -0.13; P = 0.004)
18 Łuszczak et al. 2026systematic reviewStandardized extracts of Withania somnifera and Rhodiola rosea; W. somnifera 120-1000 mg/day; R. rosea 290-1500 mg/day; 3-16 weeks; vs. Control groups of included RCTsCognitive functions: improved
34 Tandon et al. 2020systematic reviewAshwagandha root preparationsMemory and cognitive improvement: improved
35 Ng et al. 2020systematic reviewWithania somnifera (Ashwagandha) extract; vs. placebo (randomized, double-blind, placebo-controlled trials)performance on cognitive tasks: improved; executive function: improved; attention: improved
53 Gopukumar et al. 2021randomised controlled · 130 participantsAshwagandha root extract 300 mg sustained-release capsule (Prolanza™, Ashwagandha SR); one capsule daily; 90 days; vs. placebo, double-blind, randomizedfirst attempt memory score: improved (12.9 ± 6.7 vs. 10.1 ± 6.3); total error rate in recalling patterns: improved (17.5 ± 23.3 vs. 27.7 ± 23.6)
65 Langade et al. 2021randomised controlled · 80 participantsAshwagandha root extract; 8 weeks; vs. PlaceboMental alertness on rising: improved (p 0.01)
80 Baker et al. 2022randomised controlled · 60 participantsFull spectrum ashwagandha root extract; 700 mg per day, one capsule twice daily; 30 days; vs. Placebo (glycerol capsules)Perceived mental clarity: improved
85 Leonard et al. 2024randomised controlled · 59 participantsAshwagandha root and leaf extract with liposomal coating; 225 mg acutely and 225 mg/d for 30 days; 30 days; acute at 60 minutes; vs. Placebo (Gum Arabic), randomized double-blindWord Recall (correct and recalled attempts): improved; Choice Reaction Time (targets identified): improved; Picture Recognition (yes correct responses, reaction time): improved

Further studies in this area: 87 91 96 101 104 105 108 109 116 122 128 135 140 162 165 170

Ashwagandha, Physical Performance and Muscle Strength: Human Studies

With strength training, maximum strength increased more under ashwagandha extracts than under placebo in several randomized controlled trials 616286131. Maximum oxygen uptake as a measure of endurance increased more than under placebo in several randomized controlled trials 616292106127. Muscle circumference also increased more 6286, and creatine kinase as a marker of muscle stress decreased 86106; a randomized controlled trial with interval training found no difference in endurance 111. A meta-analysis found better muscle strength in physically active people, but no difference in untrained people 5, and a randomized controlled trial showed no difference in muscle soreness 99. A systematic review considers an additional benefit to strength training possible, but rates the certainty of evidence as low 16; many studies are small and short.

StudyDesign · participantsPreparation · dose · duration · comparisonResult
1 Ferreira et al. 2025systematic review · 9,005 participantsAshwagandha supplementation; mostly 500–1000 mg per dayendurance and muscular strength: improved
3 Wang et al. 2025meta-analysis · 2,062 participantsWithania somnifera (ashwagandha) among 14 other plant substances; vs. Standard treatment or other plant substancesPhysical functioning: improved (SMD = 7.78, 95% CI: 6.61-8.96)
5 Zhu et al. 2026meta-analysis · 1,249 participantsAshwagandha supplementation (Withania somnifera); vs. Control (placebo or no supplementation)Muscle strength: improved (SMD = 0.58; 95% CI: 0.12-1.04; P = 0.013); Muscle strength in physically active individuals: improved (SMD = 1.03; 95% CI: 0.56-1.49; P < 0.001); Muscle strength in untrained or special populations: no difference
9 Li et al. 2026meta-analysis · 599 participantsOral Withania somnifera (ashwagandha) supplementation; 500-600 mg/day most evidence-supported; vs. Placebo or control conditionOverall exercise performance: improved (Hedges' g = 0.47, 95% CI [0.25, 0.69], p < 0.001); Aerobic endurance: improved (g = 0.54, 95% CI [0.22, 0.85], p = 0.002); Strength performance: unclear
15 Pérez-Gómez et al. 2020meta-analysis · 162 participantsAshwagandha supplementation; vs. Control group (RCT)Maximum oxygen consumption (VO2max): improved (p = 0.04)
16 Lee et al. 2026systematic review · 161 participantsstandardized ashwagandha extract (root or root-and-leaf); vs. placebo alongside resistance training1-RM bench press: improved (SMD 0.60, 95% CI 0.20-1.01); lower-body 1-RM: improved (0.52, 0.19-0.86)
18 Łuszczak et al. 2026systematic reviewStandardized extracts of Withania somnifera and Rhodiola rosea; W. somnifera 120-1000 mg/day; R. rosea 290-1500 mg/day; 3-16 weeks; vs. Control groups of included RCTsMuscle strength and recovery: improved
54 Tamoli et al. 2023randomised controlled · 103 participantsSmotect tablets, nicotine-free herbal blend containing Withania somnifera; 2 tablets twice daily; 90 days; vs. Placebo tabletsEnergy and stamina levels: improved

Further studies in this area: 61 62 69 86 89 92 99 106 111 116 118 127 131 142 157 160 162 166

Ashwagandha, Metabolism, Blood Sugar and Weight: Human Studies

In overweight and chronic stress, standardized root extracts improved body weight and body mass index in several randomized controlled trials 5688. Body composition also improved: a root extract lowered body fat percentage in young men with strength training 86, an aqueous extract of root and leaf (Sensoril®) improved the android/gynoid ratio in recreationally active men 131. In the lipid profile, triglycerides decreased under a standardized extract 75 and several cholesterol values under a mixture with Syzygium cumini 134; neither of the two summaries mentions a comparison with the control group. In a randomized controlled trial with interval training, lipids and body composition remained unchanged 113. A meta-analysis found no influence on body weight and body fat percentage 5, and milk enriched with tryptophan did not change body composition 117. Ashwagandha slightly lowered fasting blood glucose compared with placebo in a meta-analysis, with very low certainty of evidence 8.

StudyDesign · participantsPreparation · dose · duration · comparisonResult
5 Zhu et al. 2026meta-analysis · 1,249 participantsAshwagandha supplementation (Withania somnifera); vs. Control (placebo or no supplementation)Body weight: no difference; Body fat percentage: no difference
8 Farrin et al. 2026meta-analysis · 667 participantsAshwagandha (Withania somnifera) supplementation; not reported; not reported; vs. PlaceboFasting blood glucose: improved (WMD, -3.09 mg/dL; 95% CI, -5.61 to -0.58); HbA1c: unclear (WMD, -0.05%; 95% CI, -0.47 to 0.36)
16 Lee et al. 2026systematic review · 161 participantsstandardized ashwagandha extract (root or root-and-leaf); vs. placebo alongside resistance trainingbody fat: no difference (-0.32, -0.72-0.08)
26 Quinones et al. 2025systematic reviewAshwagandha (form not specified)Weight loss: improved; Leptin and insulin sensitivity: improved
34 Tandon et al. 2020systematic reviewAshwagandha root preparationsEfficacy in type-2 diabetes: improved
36 Durg et al. 2020systematic reviewWithania somnifera (Indian ginseng), preparation not specified; vs. control/placebo in included studiesblood glucose (experimental data): improved (mean difference, -196.27; 95% confidence interval [-220.96, -171.58]; p < .00001); glycosylated haemoglobin (HbA1c): improved; insulin: improved
56 Pakhale et al. 2025randomised controlled · 100 participantsAshwagandha root extract (ARE); 300 mg twice daily; 24 weeks; vs. PlaceboBody weight: improved (-8.46 ± 3.86 kg); Body mass index: improved (-3.31 ± 1.57 kg/m2)
75 Pattojoshi et al. 2026randomised controlled · 60 participantsAshwagen®, standardized Withania somnifera extract, 300 mg capsule; 300 mg twice daily; 60 days; vs. Placebo, randomized, double-blindTriglycerides: improved (13.00%); LDL: unclear (favorable trends in LDL)

Further studies in this area: 86 88 113 117 131 134 137 143 152 166 169

Ashwagandha and Thyroid: Human Studies

For the thyroid, the studies show no uniform picture: a randomized controlled trial with root extract found an improvement in thyroid hormones in adults with subclinical hypothyroidism 90, and a systematic review reports more favorable values under ashwagandha than under placebo in primary hypothyroidism 14. This is contrasted by randomized controlled trials that found no difference in the thyroid hormone profile in healthy adults under standardized root extracts 6495. The strength of evidence is moderate: the findings are based predominantly on small studies and reviews with inconsistently named extracts, while the meta-analysis with the most participants saw an advantage only for T4, not for TSH and T3 4. Mainly root powder and standardized root extracts were studied; for specifically defined extracts such as KSM-66 or Shoden and for combination preparations, reliable data on thyroid function are lacking. It remains open whether and at which baseline values an effect exists. It also remains open whether risks arise in thyroid patients 158.

StudyDesign · participantsPreparation · dose · duration · comparisonResult
4 Fornalik et al. 2026meta-analysis · 1,706 participantsOral ashwagandha supplementation (Withania somnifera); not reported; subgroups by withanolide content; vs. PlaceboTSH: no difference; T3: no difference; T4: improved (MD = 0.61 µg/dL, p = 0.02)
14 Javidi et al. 2023systematic review · 186 participantsAshwagandha (extract not further specified); 4 and 8 weeks; vs. PlaceboT3 increase from baseline: improved (18.6% (p=0.012) and 41.5% (p < 0.001)); T4 increase from baseline: improved (9.3% (p= 0.002) and 19.6% (p < 0.001)); TSH decrease versus placebo: improved (p <0.001)
21 Tallon et al. 2026systematic reviewAshwagandha (Withania somnifera), unspecified; vs. no control group; narrative evidence assessmentThyroid function: no difference (no adverse effects)
23 Vollmer et al. 2026systematic reviewAshwagandha (Withania somnifera)thyroid hormones in hypothyroid contexts: improved
34 Tandon et al. 2020systematic reviewAshwagandha root preparationsEfficacy in subclinical hypothyroidism: improved
64 Verma et al. 2021randomised controlled · 80 participantsAshwagandha root extract 300 mg; 300 mg twice daily, orally; 8 weeks; vs. Placebo of same dosageThyroid hormonal profile: no difference
90 Sharma et al. 2018randomised controlled · 50 participantsAshwagandha root extract (Withania somnifera); 600 mg daily; 8 weeks; vs. Placebo (starch)Serum TSH: improved (p < 0.001); Serum T3: improved (p = 0.0031); Serum T4: improved (p = 0.0096)
95 Vaidya et al. 2026randomised controlled · 40 participantsStandardized Ashwagandha root extract capsules, ≥5.00 mg withanolides (HPLC-PDA, USP-NF); 200 mg twice daily; 180 days; vs. Placebo, double-blind, randomized 1:1Thyroid hormone levels: no difference

Further studies in this area: 155 158 159

Ashwagandha, Skin and Hair: Human Studies

In hair loss, a randomized controlled trial with a topical ashwagandha root extract serum showed higher hair density as well as less hair loss, more hair growth and greater hair thickness 73. A randomized controlled trial on a lotion with standardized ashwagandha root extract found a better physician's global assessment of the skin, lower water loss, more skin moisture and higher skin elasticity, while the melanin index remained unchanged 120. The strength of evidence is moderate; the studies are small, and the results apply in each case to the form and preparation studied.

StudyDesign · participantsPreparation · dose · duration · comparisonResult
73 Yerram et al. 2023randomised controlled · 61 participantsTopical Ashwagandha root extract serum; 75 days; vs. Placebo (topical)Hair shedding in 60 Seconds Hair Comb test: improved; Hair density: improved (7.3 vs. 2.8, P < 0.001); Hair growth: improved (21.7 vs. 4.2, P < 0.001)
107 Jillella et al. 2026randomised controlledStandardized Ashwagandha root extract capsule; 300 mg twice daily; 75 days; vs. PlaceboTransepidermal water loss (TEWL): improved; Hair density, growth, anagen, telogen, anagen:telogen ratio: improved (p < 0.05); Skin-specific quality of life (DLQI): improved (p < 0.05)
120 Narra et al. 2023randomised controlledLotion with 8% standardized Ashwagandha root extract; 8% extract, topical, 60 days; 60 days; vs. Placebo lotionTotal physician assessment score: improved (-74.69%); Transepidermal water loss (TEWL): improved (-15.12%); Skin hydration: improved (20.66%)
125 Maloh et al. 2022randomised controlledInnerCalm (oral) and SuperCalm (topical), botanical ingredients incl. ashwagandha; 8 weeks; vs. Oral, topical, and combined groups; compared to baselineFacial redness: improved (p < 0.001); Facial pigmentation: improved (p < 0.05)
168 Ahmed et al. 2025reviewAshwagandha among other herbal hair loss remedieshair growth in hair loss: unclear

Ashwagandha: Further Outcomes in Studies

Mood and psychological well-being improved more under ashwagandha extracts than under placebo in several randomized controlled trials 46475359. Quality of life improved more than under placebo in several randomized controlled trials 5657618992; a meta-analysis on sleep, by contrast, found no influence on quality of life 12. In women, root extract improved sexual function more than placebo in several randomized controlled trials 637293. C-reactive protein decreased more than under placebo in frail older people 116, while two studies in schizophrenia found no difference in inflammatory markers 94130. In controlled studies, serious adverse events did not occur more frequently than under placebo 4064. However, a systematic review reports liver injuries in connection with ashwagandha-containing products, including multi-ingredient formulations 17. The findings apply to the form studied in each case, such as standardized root extracts, root powder or extracts of root and leaf; the robustness is high, while the transferability to other extracts and long-term safety remain open.

StudyDesign · participantsPreparation · dose · duration · comparisonResult
2 Coope et al. 2026systematic review · 2,317 participantsStandardised Ashwagandha root extract (SARE), root only; 125 to 600 mg/day; Single dose to 180 days; vs. Comparator groups in randomised trialsHepatic, renal, haematological, endocrine and cardiovascular biomarkers: no difference; Serious adverse events
3 Wang et al. 2025meta-analysis · 2,062 participantsWithania somnifera (ashwagandha) among 14 other plant substances; vs. Standard treatment or other plant substancesQuality of life: improved (SMD = 4.66, 95% CI: 3.47-5.85); Role functioning: improved (SMD = 8.10, 95% CI: 6.89-9.32); Emotional functioning: improved (SMD = 5.71, 95% CI: 4.81 to 6.61)
4 Fornalik et al. 2026meta-analysis · 1,706 participantsOral ashwagandha supplementation (Withania somnifera); not reported; subgroups by withanolide content; vs. PlaceboSerotonin: improved (MD = 31.75 ng/ml, p < 0.01)
12 Cheah et al. 2021meta-analysis · 400 participantsAshwagandha extract; Subgroup ≥600 mg/day; Subgroup ≥8 weeks; vs. PlaceboMental alertness on rising: improved; Quality of life: no difference
16 Lee et al. 2026systematic review · 161 participantsstandardized ashwagandha extract (root or root-and-leaf); vs. placebo alongside resistance trainingchest circumference: improved (0.86, 0.41-1.31)
17 McIntyre et al. 2026systematic review · 25 participantssingle-ingredient ashwagandha products or multi-ingredient formulations containing ashwagandha; liver injury typically after weeks of use; vs. no control group, scoping review of case reports and case seriesashwagandha-associated liver injury: worsened (25 patients); acute liver failure requiring transplantation: worsened (one case); deaths among patients with pre-existing cirrhosis: worsened (three deaths)
18 Łuszczak et al. 2026systematic reviewStandardized extracts of Withania somnifera and Rhodiola rosea; W. somnifera 120-1000 mg/day; R. rosea 290-1500 mg/day; 3-16 weeks; vs. Control groups of included RCTsDepressive symptoms: improved
20 Alsanie et al. 2026meta-analysisAshwagandha (Withania somnifera) supplements; Dose-response analysis of administered dosages; vs. Control groups of included RCTsDepression (SMD): improved (SMD = -5.68; 95 % CI: -8.43 to -2.94)

Further studies in this area: 24 25 26 27 29 30 32 33 34 36 37 39 40 41 42 44 45 46 47 48 49 50 51 53 54 55 56 57 58 59 60 61 63 64 67 68 70 72 73 74 75 76 77 79 80 87 88 89 92 93 94 95 97 100 101 102 103 105 109 110 111 112 114 115 116 117 118 119 120 121 123 124 125 126 127 128 129 130 131 133 136 137 138 139 140 141 142 144 145 146 148 149 150 151 152 154 155 158 159 160 161 162 163 165 166 167 169 172 173 174 175 176

4. How Is Ashwagandha Dosed? Preparation, Dose and Duration in Studies

The studies predominantly used standardized root extracts, some named specifically such as KSM-66, Shoden, AshwaSR, Prolanza or Witholytin. In addition, root powder and extracts from root and leaf were used, such as Sensoril. For skin and hair, a topical root extract serum and a lotion with standardized root extract were tested; some of the studies investigated combination preparations whose other ingredients are named in each case.

Preparation or formDoseDurationStudy
Standardized Ashwagandha root extract (500 mg aqueous root extract) orally500 mg dailyup to week 28, monitoring every 4 weeks39
Ashwagandha root extract (ARE)600 mg/day in two divided doses8 weeks40
Withania somnifera (WS), oral500 mg for 12 weeks12 weeks41
BV-4051, polyherbal Ayurvedic formulation (Ashwagandha, Boswellia, Ginger, Turmeric)—14 days42
Ashwagandha root extract (ARE), melatonin (MLT), combination, or placeboARE 300 mg twice daily; MLT 3 mg/day; combination ARE 600 mg/day + MLT 3 mg/dayeight weeks43
Withania somnifera (WS, Ashwagandha)—8 weeks (interim analysis of a 16-week study)44
standardized ashwagandha extract (Shoden®)120 mg once dailysix weeks45
Proprietary ashwagandha root extract (APB) vs. ashwagandha root extract (ARE) vs. placebo300 mg APB twice daily8 weeks46
Ashwagandha root extract sustained-release (AshwaSR) capsules150 mg or 300 mg once daily60 days47
Shatavari root extract with Ashwagandha root extract (SHT-ARE)—8 weeks48
Ashwagandha root extract combined with Shatavari root extract (ARE-SHT)—8 weeks49
Ashwagandha root extract sustained-release capsules (AshwaSR)150 mg or 300 mg once daily60 days50
CL18100F4, blend of Withania somnifera root and Abelmoschus esculentus fruit extracts300 or 500 mg daily60 days51
Aqueous Withania somnifera root and leaf extract (WS)125, 250 or 500 mg/day8 weeks52
Ashwagandha root extract 300 mg sustained-release capsule (Prolanza™, Ashwagandha SR)one capsule daily90 days53

5. Is Ashwagandha Safe? Side Effects in Studies

Controlled studies reported no differences in liver, kidney and blood values or in serious adverse events 22534394064. Mild and temporary complaints such as gastrointestinal complaints, headache, drowsiness or soft stool were frequently mentioned 2343940. However, a systematic review reports liver injuries in connection with Ashwagandha-containing products, including multi-ingredient formulations 17.

StudyReported side effects
2 Coope et al. 2026Mild gastrointestinal discomfort, headache, transient drowsiness; no serious events
3 Wang et al. 2025Withania somnifera reduced treatment side effects (fatigue, pain, nausea)
6 Ahmadian et al. 2022no serious side effects reported
8 Farrin et al. 2026not reported
10 Arumugam et al. 2024Mild to moderate adverse events in four studies
12 Cheah et al. 2021No serious side effects reported; safety data limited
13 Fatima et al. 2024Safety assessed, no details in abstract
17 McIntyre et al. 2026cholestatic/mixed hepatitis, jaundice, pruritus; 1 acute liver failure requiring transplantation, 3 deaths in pre-existing cirrhosis
21 Tallon et al. 2026no adverse effects on thyroid, hormones, or reproduction reported
25 Marchi et al. 2025no significant difference in safety and tolerability
29 Diantini et al. 2023Safety of plants confirmed; interactions with remdesivir, favipiravir, lopinavir, ritonavir noted
30 Gómez et al. 2023No serious adverse events reported

6. What Remains Open: Limits of the Evidence

  • Many studies are small and short; treatment durations differ considerably.
  • The extracts studied have inconsistent compositions, so it remains open which preparation and dose work most reliably.
  • For root powder and for preparations for application to skin and hair, robust data are lacking for several endpoints.
  • The fertility findings come from men; corresponding studies for women are still pending.
  • Long-term safety, especially for the liver, has not been clarified.

7. Bottom Line: What Is Established About Ashwagandha

Ashwagandha has been studied in numerous controlled human studies as root powder, as standardized root extract and as extract from root and leaf. Improvements in stress and anxiety, sleep quality, sperm parameters and sexual function, and physical performance and cognitive abilities are best supported. For body weight and blood sugar, the findings are mixed, and the data on the thyroid show no uniform picture.

The results apply in each case to the form and preparation studied and cannot readily be transferred to other extracts. Many studies are small and short, and some of the evidence comes from combination preparations. Tolerability was mostly unremarkable in the controlled studies, but a systematic review reports liver injuries in connection with Ashwagandha-containing products.

Frequently Asked Questions

How well has Ashwagandha been studied in humans?

We evaluated 179 human studies on Ashwagandha, including 94 randomised controlled trials and 38 meta-analyses or systematic reviews; the controlled studies include 7,658 participants in total. As of 3 October 2026.

Does Ashwagandha help with stress and anxiety? What the studies show

We evaluated 15 meta-analyses or systematic reviews, 42 controlled studies and 16 further studies; the controlled studies include 2,749 participants in total. Result of the controlled studies: mostly improved. Strength of evidence under our published rules: high. Sources: 1247

Does Ashwagandha help with hormones and fertility? What the studies show

We evaluated 11 meta-analyses or systematic reviews, 23 controlled studies and 10 further studies; the controlled studies include 1,441 participants in total. Result of the controlled studies: mostly improved. Strength of evidence under our published rules: high. Sources: 1245

Does Ashwagandha help with sleep? What the studies show

We evaluated 5 meta-analyses or systematic reviews, 26 controlled studies and 13 further studies; the controlled studies include 1,752 participants in total. Result of the controlled studies: mostly improved. Strength of evidence under our published rules: high. Sources: 1121318

Does Ashwagandha help with memory and concentration? What the studies show

We evaluated 3 meta-analyses or systematic reviews, 16 controlled studies and 5 further studies; the controlled studies include 503 participants in total. Result of the controlled studies: mostly improved. Strength of evidence under our published rules: high. Sources: 5183435

Does Ashwagandha help with physical performance and muscle strength? What the studies show

We evaluated 5 meta-analyses or systematic reviews, 14 controlled studies and 7 further studies; the controlled studies include 521 participants in total. Result of the controlled studies: mostly improved. Strength of evidence under our published rules: high. Sources: 1359

Does Ashwagandha help with metabolism, blood sugar and weight? What the studies show

We evaluated 6 meta-analyses or systematic reviews, 8 controlled studies and 5 further studies; the controlled studies include 329 participants in total. Result of the controlled studies: mostly improved. Strength of evidence under our published rules: high. Sources: 581626

Which forms of Ashwagandha were studied in human studies?

Mainly standardized root extracts were studied, some named specifically such as KSM-66, Shoden, AshwaSR, Prolanza or Witholytin. In addition, root powder and extracts from root and leaf were used, such as Sensoril. For skin and hair, a topical root extract serum and a lotion with standardized root extract were tested.

How good is the evidence for stress and anxiety?

For stress and anxiety, numerous controlled studies are available; a meta-analysis and a systematic review showed improvements 1038. Anxiety improved more than with placebo in several randomized controlled studies 46757884. However, individual randomized controlled studies found no difference in perceived stress 94121124.

Do the studies show effects on sleep?

For sleep problems, standardized root extracts showed better sleep quality, shorter sleep latency, longer sleep duration and higher sleep efficiency in several controlled studies 456582. Wake time after falling asleep also improved 4565. For total time in bed, however, there was no difference 13.

Is there evidence of effects in men and women?

In healthy men, root extract improved sperm values and sexual function more than placebo in randomized controlled studies 5766; in women, sexual function improved 637293.

How tolerable is Ashwagandha in the studies?

Controlled studies reported no differences in liver, kidney and blood values or in serious adverse events 22534394064. Mild and temporary complaints such as gastrointestinal complaints, headache, drowsiness or soft stool were frequently mentioned 2343940. However, a systematic review reports liver injuries in connection with Ashwagandha-containing products, including multi-ingredient formulations 17.

Sources

  1. 1
  2. 2
  3. 3
  4. 4
    Fornalik M, Malkiewicz A, Adamczak D, Nawrocki F, Zielinska A, Mondal SA · 2026
  5. 5
  6. 6
    Ahmadian M, Salari R, Noras MR, Bahrami-Taghanaki HR · 2022
  7. 7
  8. 8
  9. 9
  10. 10
    Arumugam V, Vijayakumar V, Balakrishnan A, B Bhandari R, Boopalan D, Ponnurangam R et al. · 2024
  11. 11
  12. 12
  13. 13
    Fatima K, Malik J, Muskan F, Raza G, Waseem A, Shahid H et al. · 2024
  14. 14
  15. 15
    Pérez-Gómez J, Villafaina S, Adsuar JC, Merellano-Navarro E, Collado-Mateo D · 2020
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
    Morgado A, Tsampoukas G, Sokolakis I, Schoentgen N, Urkmez A, Sarikaya S · 2024
  29. 29
  30. 30
  31. 31
    Lorca C, Mulet M, Arévalo-Caro C, Sanchez MÁ, Perez A, Perrino M et al. · 2023
  32. 32
  33. 33
    Analysis of Clinical Trial Registry of India for Evidence of Anti-Arthritic Properties of Withania somnifera (Ashwagandha)
    Kanjilal S, Gupta AK, Patnaik RS, Dey A · 2021
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
    Pandit S, Srivastav AK, Sur TK, Chaudhuri S, Wang Y, Biswas TK · 2024
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61
  62. 62
  63. 63
  64. 64
  65. 65
  66. 66
  67. 67
  68. 68
  69. 69
    Darshani Mohan, Subhashree Aparimita, Supriya H. Raut* · European Journal Pharmaceutical and Medical Research · 2025
  70. 70
    Effects of a standardized extract of Withania somnifera (Ashwagandha) on depression and anxiety symptoms in persons with schizophrenia participating in a randomized, placebo-controlled clinical trial
    Gannon JM, Brar J, Rai A, Chengappa KNR · 2019
  71. 71
  72. 72
  73. 73
  74. 74
  75. 75
  76. 76
  77. 77
  78. 78
  79. 79
  80. 80
  81. 81
  82. 82
  83. 83
  84. 84
  85. 85
    Leonard M, Dickerson B, Estes L, Gonzalez DE, Jenkins V, Johnson S et al. · 2024
  86. 86
  87. 87
  88. 88
  89. 89
  90. 90
  91. 91
  92. 92
  93. 93
  94. 94
  95. 95
  96. 96
  97. 97
  98. 98
  99. 99
  100. 100
  101. 101
  102. 102
  103. 103
  104. 104
  105. 105
  106. 106
  107. 107
  108. 108
  109. 109
  110. 110
  111. 111
  112. 112
  113. 113
    Charmas M, Jówko E, Długołęcka B, Klusiewicz A, Przybylska I, Galczak-Kondraciuk A · 2025
  114. 114
  115. 115
    Pérez-Piñero S, Muñoz-Carrillo JC, Echepare-Taberna J, Luque-Rubia AJ, Millán Rivero JE, Muñoz-Cámara M et al. · 2024
  116. 116
  117. 117
    Pérez-Piñero S, Muñoz-Carrillo JC, Echepare-Taberna J, Muñoz-Cámara M, Herrera-Fernández C, Ávila-Gandía V et al. · 2024
  118. 118
  119. 119
  120. 120
  121. 121
  122. 122
    Remenapp A, Coyle K, Orange T, Lynch T, Hooper D, Hooper S et al. · 2022
  123. 123
  124. 124
  125. 125
    Maloh J, Chakkalakal M, Sulaiman F, Burney W, Chambers CJ, Sivamani RK · 2022
  126. 126
  127. 127
  128. 128
  129. 129
  130. 130
  131. 131
    Ziegenfuss TN, Kedia AW, Sandrock JE, Raub BJ, Kerksick CM, Lopez HL · 2018
  132. 132
  133. 133
    Efficacy of Different Concentrations of Withanolides in Ashwagandha Supplements for Insomnia and Enhancing Energy Level
    · 2022
  134. 134
    Zubair K, Zafar F, Saif S, Khaliq U, Syed H, Sarfraz A et al. · 2026
  135. 135
    Xing D, Yoo C, Gonzalez D, Jenkins V, Nottingham K, Dickerson B et al. · 2022
  136. 136
  137. 137
  138. 138
  139. 139
  140. 140
    Evaluation of Self-Reported Stress Reduction from Ashwagandha and B Vitamin Supplementation Using Ecological Momentary Assessment (EMA)
    Li I, Pacanowski C, Cao L, Chai S · 2020
  141. 141
  142. 142
  143. 143
  144. 144
  145. 145
    Philips CA, Philips CA, Valsan A, Theruvath AH, Ravindran R, Oommen TT et al. · 2023
  146. 146
    Pérez Pérez S, Zumaqué-Valverde E, Saavedra Chacón MF, Arteta Cueto AA · 2026
  147. 147
  148. 148
  149. 149
  150. 150
  151. 151
    Effects of Four-Week Supplementation of Ashwagandha and B-Vitamins on Mood and Stress Relief
    Chai S, Li I, Pacanowski C, Brewer B · 2020
  152. 152
  153. 153
  154. 154
  155. 155
  156. 156
    Zbozinek TD, Khalsa SS, Craske MG · 2026
  157. 157
  158. 158
  159. 159
  160. 160
  161. 161
  162. 162
  163. 163
  164. 164
    Skrzypiec-Spring M, Pokrywka A, Kuliczkowska-Płaksej J, Szeląg A, Bolanowski M · 2025
  165. 165
    Jamnekar PP, Dehankar TJ, Bedre RV, Dharan BG, Agravat B, Agravat H · 2025
  166. 166
  167. 167
  168. 168
    Ahmed A, Alali AM, Abdullah E, Alharbi MN, Alayoubi HM · 2025
  169. 169
  170. 170
    Moise G, Jîjie AR, Moacă EA, Predescu IA, Dehelean CA, Hegheș A et al. · 2024
  171. 171
  172. 172
  173. 173
  174. 174
  175. 175
    Woo SM, Davis WD, Aggarwal S, Clinton JW, Kiparizoska S, Lewis JH · 2021
  176. 176
    Sengupta P, Agarwal A, Pogrebetskaya M, Roychoudhury S, Durairajanayagam D, Henkel R · 2018
  177. 177
    Wagner H, Nörr H, Winterhoff H · 1994

Every statement on this page carries its evidence tier — proven, plausible or hypothesis — and leads to the original work. The decision in the individual case rests with the practitioner; we provide the connections.

International Health Research · https://ih-research.com/en/knowledge/ashwagandha/ · Last updated: 2026-10-15